Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rule

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Leukemia & Lymphoma|September 17, 2009
The Simplified Mantle-Cell Lymphoma International Prognostic Index predicts overall survival but not progression-free survival in patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide +/- rituximab: results of a randomized phase II trialHeather E Eve, Jo Gambell, Paul Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Time to treatment does not influence overall survival in newly diagnosed mantle-cell lymphomaHeather E Eve, Michelle V Furtado, Michael D Hamon, et al.
Plos One|June 12, 2013
Environmental influences on kelp performance across the reproductive period: an ecological trade-off between gametophyte survival and growth?Margaret B Mohring, Gary A Kendrick, Thomas Wernberg, et al.
European Journal of Cancer Care|March 10, 2009
Chemotherapy in the community: what do patients want?E Pace, S Dennison, J Morris, et al.
Thrombosis and Haemostasis|January 17, 2003
Allelic discrimination of factor V Leiden using the GeneAmp 5700 Sequence Detection SystemS E Monk, A W Duckworth, J Farrugia, et al.
Acta Haematologica|November 13, 2009
Activity of thalidomide and lenalidomide in mantle cell lymphomaS J Richardson, H E Eve, J A Copplestone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
Indolent mantle-cell lymphoma: immunoglobulin variable region heavy chain sequence analysis reveals evidence of disease 10 years prior to symptomatic clinical presentationSimon A J Rule, Sarah Poplar, Paul A S Evans, et al.
Marine Pollution Bulletin|December 24, 2021
Macro marine litter survey of sandy beaches along the Cox's Bazar Coast of Bay of Bengal, Bangladesh: Land-based sources of solid litter pollutionMd Refat Jahan Rakib, Alperen Ertaş, Tony R Walker, et al.
Leukemia & Lymphoma|February 7, 2009
Toxicity of fludarabine and cyclophosphamide with or without rituximab as initial therapy for patients with previously untreated mantle cell lymphoma: results of a randomised phase II studyHeather E Eve, David Linch, Wendi Qian, et al.
Leukemia & Lymphoma|July 16, 2005
Superior quality and duration of responses among patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide with or without rituximab compared with prior responses to CHOPD Wayne Thomas, Roger G Owen, Stephen A N Johnson, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Leukemia & Lymphoma|September 17, 2009
The Simplified Mantle-Cell Lymphoma International Prognostic Index predicts overall survival but not progression-free survival in patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide +/- rituximab: results of a randomized phase II trialHeather E Eve, Jo Gambell, Paul Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2009
Time to treatment does not influence overall survival in newly diagnosed mantle-cell lymphomaHeather E Eve, Michelle V Furtado, Michael D Hamon, et al.
Plos One|June 12, 2013
Environmental influences on kelp performance across the reproductive period: an ecological trade-off between gametophyte survival and growth?Margaret B Mohring, Gary A Kendrick, Thomas Wernberg, et al.
European Journal of Cancer Care|March 10, 2009
Chemotherapy in the community: what do patients want?E Pace, S Dennison, J Morris, et al.
Thrombosis and Haemostasis|January 17, 2003
Allelic discrimination of factor V Leiden using the GeneAmp 5700 Sequence Detection SystemS E Monk, A W Duckworth, J Farrugia, et al.
Acta Haematologica|November 13, 2009
Activity of thalidomide and lenalidomide in mantle cell lymphomaS J Richardson, H E Eve, J A Copplestone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
Indolent mantle-cell lymphoma: immunoglobulin variable region heavy chain sequence analysis reveals evidence of disease 10 years prior to symptomatic clinical presentationSimon A J Rule, Sarah Poplar, Paul A S Evans, et al.
Marine Pollution Bulletin|December 24, 2021
Macro marine litter survey of sandy beaches along the Cox's Bazar Coast of Bay of Bengal, Bangladesh: Land-based sources of solid litter pollutionMd Refat Jahan Rakib, Alperen Ertaş, Tony R Walker, et al.
Leukemia & Lymphoma|February 7, 2009
Toxicity of fludarabine and cyclophosphamide with or without rituximab as initial therapy for patients with previously untreated mantle cell lymphoma: results of a randomised phase II studyHeather E Eve, David Linch, Wendi Qian, et al.
Leukemia & Lymphoma|July 16, 2005
Superior quality and duration of responses among patients with mantle-cell lymphoma treated with fludarabine and cyclophosphamide with or without rituximab compared with prior responses to CHOPD Wayne Thomas, Roger G Owen, Stephen A N Johnson, et al.
Pageof 6